| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T31 |
0-200 |
Sentence |
denotes |
We have recently designed and engineered a pan-CoV fusion inhibitor, EK1 peptide, which could inhibit infection of five human coronaviruses, including SARS-CoV and MERS-CoV, and three bat-SL-CoVs [7]. |
| T32 |
201-437 |
Sentence |
denotes |
Intranasal application of EK1 peptide before or after viral challenge, EK1 peptide can protect human DPP4-transgenic mice from MERS-CoV infection, suggesting its potential prophylactic and therapeutic effect against 2019-nCoV infection. |
| T33 |
438-634 |
Sentence |
denotes |
Once confirmed, we will develop EK1 peptide as a t prophylactic or therapeutic for intranasal application to prevent or treat infection by 2019-nCoV and other emerging coronaviruses in the future. |
